GFAP and type 2 diabetes mellitus: In particular, our current study demonstrated that the expression of GFAP (a well-known marker for activated SGCs) was higher in the SGCs from T2DM rats than from sham rats (Figure 2), which further confirms that activated SGCs could be involved in cardiac sympathetic overactivation in type 2 diabetes.